Mesenchymal Stem Cell (ucbMSC) transplant has demonstrated positive results in the treatment of Rheumatoid Arthritis. You know you need ucbMSC transplant when the patient goes through the following symptoms :-

• Resistance to normal treatment
• Ineffective drug therapy – like cytostatics and glucocorticoids
• Significant decrease in functional capacity of the joints
• Trophic disruptions in the musculoskeletal system
• Significant variations in immunologic/hematopoietic parameters

ucbMSCs are often used in patients with seronegative and seropositive arthritis of activity grades I – III and those with functional insufficiency of the joints of grades I-III.

Within days of the transplantation, patients begin to see improvements – including reducing weakness, improved motion, normalized sleep and better appetite.

Within the first three months, there is a reduction of inflammatory process activity. There is a visible reduction in joint tenderness, morning sickness and oedema.

It has been observed that in 85% of cases, patients have been able to stay without glucocorticoids and non-steroidal inflammatory drugs. X-ray data shows no progression of joint damage in 72% of patients.

With the treatment, more than 80% of patients have been able to achieve a better quality of life along with remission which lasted anywhere between six months to three years.